(Q73023685)
Statements
The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study (English)
G Kobelt
L Jönsson
A Young
1 February 2003
scientific article published on 01 February 2003